Invention Grant
- Patent Title: Treatment of ischemia reperfusion injury using alpha-2 macroglobulin
-
Application No.: US16315684Application Date: 2017-07-14
-
Publication No.: US10722557B2Publication Date: 2020-07-28
- Inventor: Antonio Abbate , Stefano Toldo
- Applicant: VIRGINIA COMMONWEALTH UNIVERSITY
- Applicant Address: US VA Richmond
- Assignee: Virginia Commonwealth University
- Current Assignee: Virginia Commonwealth University
- Current Assignee Address: US VA Richmond
- Agency: W&C IP
- International Application: PCT/US2017/042125 WO 20170714
- International Announcement: WO2018/013915 WO 20180118
- Main IPC: A61P9/10
- IPC: A61P9/10 ; A61K38/55 ; A61K38/17 ; A61P7/02 ; C07K14/81 ; C07K14/705

Abstract:
Methods of preventing and/or treating reperfusion injury are provided. The methods involve administering alpha-2-macroglobulin (A2MG) to a subject with ischemia in one or more tissues or organs, in order to prevent or decrease reperfusion injury when blood flow is restored to the tissues or organs (reperfusion). In some aspects, the patient who is treated has had a heart attack (e.g. acute myocardial infarction, AMI) and the ischemic tissue that is protected from reperfusion injury is heart tissue.
Public/Granted literature
- US20190142899A1 TREATMENT OF ISCHEMIA REPERFUSION INJURY USING ALPHA-2 MACROGLOBULIN Public/Granted day:2019-05-16
Information query